In March 2025, the company announced new designs for just a direct-to-shopper providing of its Wegovy weight loss drug. The company recognized a completely new pharmacy, named NovoCare, which might demand customers $499 a month for access to the drug, fewer than half the expense of the drug by way of other pharmaceutical distribution networks.[fift